Revolution Medicines' Pancreatic Cancer Drug Nearly Doubled Survival. Is the High-Flying Stock Still a Buy?

Bản dịch chưa sẵn sàng. Đang hiển thị bài viết gốc.

Key PointsIts lead therapy is approved to treat previously treated patients with an advanced form of pancreatic cancer.

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.